| 注册
首页|期刊导航|中成药|白及提取工艺优化及其抗氧化、酪氨酸酶抑制活性评价

白及提取工艺优化及其抗氧化、酪氨酸酶抑制活性评价

王珊珊 罗益远 谢叶菲 蒋新苗 潘萍 秦昆明 陈宏降

中成药2025,Vol.47Issue(7):2171-2177,7.
中成药2025,Vol.47Issue(7):2171-2177,7.DOI:10.3969/j.issn.1001-1528.2025.07.006

白及提取工艺优化及其抗氧化、酪氨酸酶抑制活性评价

Optimization of extraction process for Bletillae Rhizoma and evaluation of its anti-oxidant,tyrosinase inhibitory activities

王珊珊 1罗益远 2谢叶菲 3蒋新苗 3潘萍 2秦昆明 1陈宏降2

作者信息

  • 1. 江苏海洋大学药学院,江苏连云港 222005
  • 2. 浙江药科职业大学中药学院,浙江宁波 315500||宁波市中药资源综合开发利用重点实验室,浙江宁波 315500
  • 3. 浙江药科职业大学中药学院,浙江宁波 315500
  • 折叠

摘要

Abstract

AIM To optimize the extraction process for Bletillae Rhizoma,and to evaluate its anti-oxidant,tyrosinase inhibitory activities.METHODS With ultrasound time,ethanol concentration and solid-liquid ratio as influencing factors,the total extraction content of gastrodin,protocatechualdehyde,p-hydroxybenzaldehyde,1,4-bis[4-(gluconoxy)benzyl]-2-isobutylmalate-2-glucoside,1,4-bis[4-(gluconoxy)benzyl]-2-isobutylmalate,yam Ⅲ,dihydropinosin and 3'-O-methylyam Ⅲ as an evaluation index,the extraction process was optimized by Box-Behnken response surface method.Subsequently,the extract's scavenging effects on DPPH,ABTS+free radicals,and inhibitory ability on tyrosinase were determined.RESULTS The optimal conditions were determined to be 49 min for ultrasound time,55%for ethanol concentration,1∶30 for solid-liquid ratio,and 2 times for extraction frequency,the total extraction content was 13.18 mg/g.The extract demonstrated the IC50 of 10.12,314.07 and 1.70 μg/g on DPPH,ABTS+free radicals and tyrosinase,respectively.CONCLUSION This simple,reliable and stable method can be used for the extraction for Bletillae Rhizoma with strong anti-oxidant,tyrosinase inhibitory activities.

关键词

白及/提取工艺/抗氧化活性/酪氨酸酶抑制活性/Box-Behnken响应面法

Key words

Bletillae Rhizoma/extraction process/anti-oxidant activity/tyrosinase inhibitory activity/Box-Behnken response surface method

分类

医药卫生

引用本文复制引用

王珊珊,罗益远,谢叶菲,蒋新苗,潘萍,秦昆明,陈宏降..白及提取工艺优化及其抗氧化、酪氨酸酶抑制活性评价[J].中成药,2025,47(7):2171-2177,7.

基金项目

浙江省公益基础研究项目(LTGN23H280004) (LTGN23H280004)

浙江省药品监督管理局科技计划项目(2023014) (2023014)

浙江省教育厅一般项目(Y202352650) (Y202352650)

宁波市自然科学基金项目(2021J187,2023J306) (2021J187,2023J306)

中成药

OA北大核心

1001-1528

访问量0
|
下载量0
段落导航相关论文